Annual Operating Profit
-$71.70 M
-$18.58 M-34.97%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual operating income is -$71.70 million, with the most recent change of -$18.58 million (-34.97%) on September 30, 2024.
- During the last 3 years, OTLK annual operating profit has fallen by -$19.98 million (-38.62%).
- OTLK annual operating profit is now -478.61% below its all-time high of -$12.39 million, reached on September 30, 2014.
Performance
OTLK Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$22.88 M
-$3.31 M-16.94%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly operating income is -$22.88 million, with the most recent change of -$3.31 million (-16.94%) on September 1, 2024.
- Over the past year, OTLK quarterly operating profit has dropped by -$12.55 million (-121.61%).
- OTLK quarterly operating profit is now -686.01% below its all-time high of -$2.91 million, reached on September 30, 2017.
Performance
OTLK Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$71.70 M
-$10.42 M-17.00%
September 1, 2024
Summary
- As of February 7, 2025, OTLK TTM operating income is -$71.70 million, with the most recent change of -$10.42 million (-17.00%) on September 1, 2024.
- Over the past year, OTLK TTM operating profit has dropped by -$23.94 million (-50.13%).
- OTLK TTM operating profit is now -1630.58% below its all-time high of -$4.14 million, reached on December 31, 2014.
Performance
OTLK TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
OTLK Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.0% | -121.6% | -50.1% |
| 3 y3 years | -38.6% | -70.3% | -38.6% |
| 5 y5 years | -186.5% | -260.8% | -192.7% |
OTLK Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -38.6% | at low | -234.6% | at low | -50.1% | at low |
| 5 y | 5-year | -186.5% | at low | -260.8% | at low | -192.7% | at low |
| alltime | all time | -478.6% | at low | -686.0% | at low | -1630.6% | at low |
Outlook Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$71.70 M(+35.0%) | - | - |
| Sep 2024 | - | -$22.88 M(+16.9%) | -$71.70 M(+17.0%) |
| Jun 2024 | - | -$19.56 M(+3.3%) | -$61.28 M(+2.4%) |
| Mar 2024 | - | -$18.94 M(+83.5%) | -$59.86 M(+25.3%) |
| Dec 2023 | - | -$10.32 M(-17.1%) | -$47.76 M(-10.1%) |
| Sep 2023 | -$53.13 M(-15.8%) | -$12.46 M(-31.3%) | -$53.13 M(-2.8%) |
| Jun 2023 | - | -$18.14 M(+165.3%) | -$54.65 M(+2.1%) |
| Mar 2023 | - | -$6.84 M(-56.4%) | -$53.54 M(-18.4%) |
| Dec 2022 | - | -$15.69 M(+12.2%) | -$65.61 M(+4.0%) |
| Sep 2022 | -$63.07 M(+21.9%) | -$13.99 M(-17.8%) | -$63.07 M(+0.9%) |
| Jun 2022 | - | -$17.02 M(-10.0%) | -$62.52 M(+9.7%) |
| Mar 2022 | - | -$18.91 M(+43.8%) | -$56.97 M(+12.4%) |
| Dec 2021 | - | -$13.15 M(-2.1%) | -$50.69 M(-2.0%) |
| Sep 2021 | -$51.73 M(+42.4%) | -$13.44 M(+17.1%) | -$51.73 M(+7.1%) |
| Jun 2021 | - | -$11.47 M(-9.1%) | -$48.30 M(-0.6%) |
| Mar 2021 | - | -$12.63 M(-11.0%) | -$48.60 M(+14.9%) |
| Dec 2020 | - | -$14.19 M(+41.7%) | -$42.32 M(+16.5%) |
| Sep 2020 | -$36.31 M(+45.1%) | -$10.01 M(-15.0%) | -$36.31 M(+18.3%) |
| Jun 2020 | - | -$11.77 M(+85.7%) | -$30.68 M(+25.2%) |
| Mar 2020 | - | -$6.34 M(-22.5%) | -$24.50 M(-3.2%) |
| Dec 2019 | - | -$8.18 M(+86.7%) | -$25.30 M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | -$25.03 M(-15.6%) | -$4.38 M(-21.6%) | -$25.03 M(-24.3%) |
| Jun 2019 | - | -$5.59 M(-21.7%) | -$33.06 M(-4.7%) |
| Mar 2019 | - | -$7.14 M(-9.7%) | -$34.69 M(+0.9%) |
| Dec 2018 | - | -$7.91 M(-36.3%) | -$34.37 M(+15.9%) |
| Sep 2018 | -$29.64 M(-17.4%) | -$12.41 M(+71.9%) | -$29.64 M(+47.2%) |
| Jun 2018 | - | -$7.22 M(+5.7%) | -$20.14 M(-0.6%) |
| Mar 2018 | - | -$6.83 M(+114.8%) | -$20.26 M(-4.7%) |
| Dec 2017 | - | -$3.18 M(+9.2%) | -$21.26 M(-40.7%) |
| Sep 2017 | -$35.88 M(-30.1%) | -$2.91 M(-60.3%) | -$35.88 M(-16.4%) |
| Jun 2017 | - | -$7.34 M(-6.4%) | -$42.92 M(-25.5%) |
| Mar 2017 | - | -$7.84 M(-56.0%) | -$57.61 M(+9.3%) |
| Dec 2016 | - | -$17.80 M(+78.8%) | -$52.73 M(+2.7%) |
| Sep 2016 | -$51.35 M(+10.3%) | -$9.95 M(-54.8%) | -$51.35 M(-12.6%) |
| Jun 2016 | - | -$22.03 M(+645.7%) | -$58.77 M(+23.0%) |
| Mar 2016 | - | -$2.95 M(-82.0%) | -$47.78 M(-18.8%) |
| Dec 2015 | - | -$16.41 M(-5.5%) | -$58.83 M(+26.4%) |
| Sep 2015 | -$46.56 M(+275.7%) | -$17.37 M(+57.3%) | -$46.56 M(+59.5%) |
| Jun 2015 | - | -$11.05 M(-21.1%) | -$29.19 M(+60.9%) |
| Mar 2015 | - | -$14.00 M(+237.9%) | -$18.14 M(+337.9%) |
| Dec 2014 | - | -$4.14 M | -$4.14 M |
| Sep 2014 | -$12.39 M | - | - |
FAQ
- What is Outlook Therapeutics annual operating income?
- What is the all time high annual operating profit for Outlook Therapeutics?
- What is Outlook Therapeutics annual operating profit year-on-year change?
- What is Outlook Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly operating profit year-on-year change?
- What is Outlook Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Outlook Therapeutics?
- What is Outlook Therapeutics TTM operating profit year-on-year change?
What is Outlook Therapeutics annual operating income?
The current annual operating profit of OTLK is -$71.70 M
What is the all time high annual operating profit for Outlook Therapeutics?
Outlook Therapeutics all-time high annual operating income is -$12.39 M
What is Outlook Therapeutics annual operating profit year-on-year change?
Over the past year, OTLK annual operating income has changed by -$18.58 M (-34.97%)
What is Outlook Therapeutics quarterly operating income?
The current quarterly operating profit of OTLK is -$22.88 M
What is the all time high quarterly operating profit for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly operating income is -$2.91 M
What is Outlook Therapeutics quarterly operating profit year-on-year change?
Over the past year, OTLK quarterly operating income has changed by -$12.55 M (-121.61%)
What is Outlook Therapeutics TTM operating income?
The current TTM operating profit of OTLK is -$71.70 M
What is the all time high TTM operating profit for Outlook Therapeutics?
Outlook Therapeutics all-time high TTM operating income is -$4.14 M
What is Outlook Therapeutics TTM operating profit year-on-year change?
Over the past year, OTLK TTM operating income has changed by -$23.94 M (-50.13%)